EΛΒΑΛΧΑΛΚΟΡ ΕΛΛΗΝΙΚΗ ΒΙΟΜΗΧΑΝΙΑ ΧΑΛΚΟΥ ΚΑΙ ΑΛΟΥΜΙΝΙΟΥ ΑΝΩΝΥΜΟΣ ΕΤΑΙΡΕΙΑ financials
EΛΒΑΛΧΑΛΚΟΡ ΕΛΛΗΝΙΚΗ ΒΙΟΜΗΧΑΝΙΑ ΧΑΛΚΟΥ ΚΑΙ ΑΛΟΥΜΙΝΙΟΥ ΑΝΩΝΥΜΟΣ ΕΤΑΙΡΕΙΑ
Country: GR Reporting currency: EUR Latest annual report: 2024-12-31
LEI:
213800EYWS2GY56AWP42 Financial statements
(EUR, as reported — unscaled; 130 line items across 2 annual periods)
| Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €3.44B | €3.29B |
| Cost of sales | €3.15B | €3.08B |
| Gross profit | €283.9M | €213.3M |
| Other income | €41.7M | €25.3M |
| Administrative expenses | €78.5M | €69.0M |
| Operating profit (EBIT) | €176.6M | €103.1M |
| Net finance income / (cost) | -€44.6M | -€52.7M |
| Finance costs | €48.4M | €56.6M |
| Profit before tax | €126.0M | €43.0M |
| Income tax expense | €16.5M | €10.1M |
| Profit for the year | €109.5M | €32.8M |
| — attributable to owners | €103.2M | €28.5M |
| — attributable to NCI | €6.3M | €4.3M |
| Total comprehensive income | €108.1M | €8.7M |
| Per share | ||
| Basic EPS | €27522.00 | €7595.00 |
| Free cash flow / share | €47183.01 | €40418.18 |
| Cash flow statement | ||
| Cash generated from operations | €322.8M | €343.5M |
| Net cash from operating activities | €263.1M | €269.8M |
| Income taxes paid | €11.7M | €19.8M |
| Net cash from investing activities | -€68.1M | -€95.0M |
| Purchase of PP&E (capex) | €75.3M | €95.0M |
| Purchase of intangibles | €432.0K | €312.0K |
| Net cash from financing activities | -€155.9M | -€169.5M |
| Dividends paid | €17.3M | €23.8M |
| Proceeds from borrowings | €0 | €54.1M |
| Repayments of borrowings | €135.8M | €194.2M |
| Lease liability payments | €3.1M | €6.0M |
| Balance sheet | ||
| Total assets | €2.45B | €2.33B |
| Non-current assets | €1.26B | €1.26B |
| Property, plant & equipment | €1.06B | €1.05B |
| Right-of-use assets | €14.8M | €10.4M |
| Intangible assets & goodwill | €78.0M | €77.1M |
| Current assets | €1.19B | €1.08B |
| Inventories | €802.0M | €734.7M |
| Trade & other receivables | €301.7M | €291.1M |
| Cash & equivalents | €79.7M | €40.5M |
| Total equity | €1.05B | €962.4M |
| — attributable to owners | €1.02B | €939.6M |
| Non-controlling interests | €27.0M | €22.8M |
| Non-current liabilities | €684.8M | €802.9M |
| Long-term borrowings | €575.1M | €694.5M |
| Lease liabilities (non-current) | €11.6M | €7.8M |
| Current liabilities | €709.1M | €568.2M |
| Short-term borrowings | €133.0M | €148.9M |
| Lease liabilities (current) | €3.4M | €2.6M |
| Trade & other payables | €553.3M | €395.3M |
| Deferred tax liabilities | €63.7M | €56.9M |
| Derived metrics | ||
| Free cash flow | €187.8M | €174.8M |
| Operating margin | 5.1% | 3.1% |
| Net margin | 3.2% | 1.0% |
| Return on equity | 10.4% | 3.4% |
| Cash conversion ratio | 2.40× | 8.21× |
| Capex coverage | 3.49× | 2.84× |
| Other reported items | ||
| Adjustments For Amortisation Expense | €1.4M | €1.1M |
| Adjustments For Decrease Increase In Inventories | -€56.3M | €122.0M |
| Adjustments For Decrease Increase In Trade and Other Receivables | -€19.4M | €11.9M |
| Adjustments For Depreciation Expense | €66.2M | €73.8M |
| Adjustments For Dividend Income | €418.0K | €434.0K |
| Adjustments For Fair Value Gains Losses | -€16.0K | €0 |
| Adjustments For Finance Income Cost | -€45.0M | -€53.1M |
| Adjustments For Gain Loss On Disposals Property Plant and Equipment | €36.0K | €264.0K |
| Adjustments For Gains Losses On Change In Fair Value of Derivatives | -€3.1M | -€3.6M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Inventories | -€11.0M | €5.2M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Property Plant and Equipment | €35.0K | €1.2M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Trade and Other Receivables | €7.9M | €0 |
| Adjustments For Income Tax Expense | €16.5M | €10.1M |
| Adjustments For Increase Decrease In Contract Liabilities | €1.3M | €2.5M |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | -€2.3M | €1.4M |
| Adjustments For Increase Decrease In Trade and Other Payables | €159.2M | €8.8M |
| Adjustments For Provisions | €0 | €7.8M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | -€2.9M | -€7.4M |
| Cash Flows From Used In Operations Before Changes In Working Capital | €240.2M | €197.0M |
| Comprehensive Income Attributable To Noncontrolling Interests | €6.3M | €4.3M |
| Comprehensive Income Attributable To Owners of Parent | €101.8M | €4.4M |
| Current Contract Liabilities | €12.3M | €10.9M |
| Current Derivative Financial Assets | €5.7M | €9.0M |
| Current Derivative Financial Liabilities | €2.8M | €3.4M |
| Current Loans and Receivables | €0 | €220.0K |
| Current Provisions | €162.0K | €182.0K |
| Current Tax Liabilities Current | €4.2M | €5.6M |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | €15.0M | €22.5M |
| Dividends Paid To Noncontrolling Interests Classified As Financing Activities | €2.3M | €1.3M |
| Dividends Received Classified As Investing Activities | €5.0M | €398.0K |
| Equity and Liabilities | €2.45B | €2.33B |
| Finance Income | €3.4M | €3.5M |
| Gains Losses On Cash Flow Hedges Before Tax | €6.1M | -€21.0M |
| Impairment Loss Impairment Gain and Reversal of Impairment Loss Determined In Accordance With IFRS9 | €7.9M | €7.8M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss | €98.0K | -€6.6M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss | -€376.0K | -€111.0K |
| Increase Decrease In Cash and Cash Equivalents | €39.2M | €5.3M |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | €0 | -€890.0K |
| Increase Decrease Through Disposal of Subsidiary | — | €0 |
| Increase Decrease Through Transactions With Owners | -€18.4M | -€24.7M |
| Increase Decrease Through Transfers and Other Changes Equity | €0 | €0 |
| Increase Decrease Through Treasury Share Transactions | -€1.1M | — |
| Interest Paid Classified As Operating Activities | €48.0M | €54.0M |
| Interest Received Classified As Investing Activities | €3.0M | €154.0K |
| Investment Accounted For Using Equity Method | €21.6M | €23.4M |
| Investment Property | €22.0M | €22.7M |
| Investments In Subsidiaries | €0 | €0 |
| Issued Capital | €146.3M | €146.3M |
| Liabilities | €1.39B | €1.37B |
| Liabilities Included In Disposal Groups Classified As Held For Sale | €0 | €1.2M |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €0 | €1.5M |
| Noncurrent Derivative Financial Assets | €3.5M | €5.4M |
| Noncurrent Derivative Financial Liabilities | €0 | €3.6M |
| Noncurrent Government Grants | €11.2M | €12.7M |
| Noncurrent Investments Other Than Investments Accounted For Using Equity Method | €35.0M | €28.5M |
| Noncurrent Provisions | €1.4M | €1.6M |
| Noncurrent Provisions For Employee Benefits | €13.8M | €13.2M |
| Noncurrent Receivables Due From Related Parties | €0 | €2.6M |
| Other Comprehensive Income | -€1.5M | -€24.2M |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | €82.0K | -€48.0K |
| Other Comprehensive Income Before Tax Gains Losses From Investments In Equity Instruments | -€902.0K | €216.0K |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€843.0K | -€790.0K |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | €177.0K | -€23.7M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | -€1.7M | -€464.0K |
| Other Expense By Function | €29.5K | €23.4M |
| Other Noncurrent Liabilities | €8.0M | €12.6M |
| Other Noncurrent Receivables | €26.6M | €34.5M |
| Other Reserves | €318.5M | €309.6M |
| Proceeds From Government Grants Classified As Financing Activities | €1.4M | €0 |
| Proceeds From Issuing Shares | €0 | €376.0K |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €271.0K | €1.0M |
| Reclassification Adjustments On Cash Flow Hedges Before Tax | €5.9M | €9.2M |
| Retained Earnings | €496.2M | €418.6M |
| Revenue From Dividends | €418.0K | €434.0K |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | -€2.9M | -€7.4M |
| Share Premium | €65.0M | €65.0M |
| Treasury Shares | €1.1M | €0 |
Methodology
Every line item above is a fact tagged in EΛΒΑΛΧΑΛΚΟΡ ΕΛΛΗΝΙΚΗ ΒΙΟΜΗΧΑΝΙΑ ΧΑΛΚΟΥ ΚΑΙ ΑΛΟΥΜΙΝΙΟΥ ΑΝΩΝΥΜΟΣ ΕΤΑΙΡΕΙΑ's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.